Kyung Dong Pharmaceutical Co. Ltd (011040) — Cash Flow Quality Index
Kyung Dong Pharmaceutical Co. Ltd (011040) has a Cash Flow Quality Index of 0.85x as of December 2025. Operating cash flow of ₩2.45 Billion is below net income of ₩2.89 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 011040 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kyung Dong Pharmaceutical Co. Ltd Cash Flow Quality Index (2011–2025)
Historical Cash Flow Quality Index for Kyung Dong Pharmaceutical Co. Ltd across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Kyung Dong Pharmaceutical Co. Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Year-by-year earnings quality comparison for Kyung Dong Pharmaceutical Co. Ltd. For live market cap and the full company financial profile, see Kyung Dong Pharmaceutical Co. Ltd (011040) total market value.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.99x | ₩16.93 Billion | ₩8.53 Billion | ▲ +234.0% |
| 2024 | -1.48x | ₩-8.07 Billion | ₩5.45 Billion | ▼ -1576.7% |
| 2022 | -0.09x | ₩-1.07 Billion | ₩12.16 Billion | ▼ -109.0% |
| 2021 | 0.98x | ₩12.42 Billion | ₩12.67 Billion | ▼ -28.6% |
| 2020 | 1.37x | ₩17.12 Billion | ₩12.46 Billion | ▲ +1094.3% |
| 2019 | -0.14x | ₩-2.78 Billion | ₩20.13 Billion | ▼ -102.2% |
| 2018 | 6.35x | ₩33.27 Billion | ₩5.24 Billion | ▲ +768.0% |
| 2017 | 0.73x | ₩14.79 Billion | ₩20.23 Billion | ▼ -49.8% |
| 2016 | 1.46x | ₩25.63 Billion | ₩17.61 Billion | ▲ +12.7% |
| 2015 | 1.29x | ₩18.26 Billion | ₩14.13 Billion | ▲ +39.4% |
| 2014 | 0.93x | ₩22.73 Billion | ₩24.52 Billion | ▲ +6.4% |
| 2013 | 0.87x | ₩16.42 Billion | ₩18.85 Billion | ▼ -64.1% |
| 2012 | 2.43x | ₩19.96 Billion | ₩8.22 Billion | ▲ +88.9% |
| 2011 | 1.28x | ₩26.08 Billion | ₩20.29 Billion | — |